AU6460300A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- AU6460300A AU6460300A AU64603/00A AU6460300A AU6460300A AU 6460300 A AU6460300 A AU 6460300A AU 64603/00 A AU64603/00 A AU 64603/00A AU 6460300 A AU6460300 A AU 6460300A AU 6460300 A AU6460300 A AU 6460300A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902938 | 1999-08-18 | ||
SE9902938A SE9902938D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
PCT/GB2000/003116 WO2001012192A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a-(2-aminoethyl)-benzothiazolone and disodium cromoglycate or nedocromil |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6460300A true AU6460300A (en) | 2001-03-13 |
Family
ID=20416696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64603/00A Abandoned AU6460300A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6460300A (en) |
SE (1) | SE9902938D0 (en) |
WO (1) | WO2001012192A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2543858C (en) | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
WO2009154557A1 (en) | 2008-06-18 | 2009-12-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902938A patent/SE9902938D0/en unknown
-
2000
- 2000-08-14 WO PCT/GB2000/003116 patent/WO2001012192A2/en active Application Filing
- 2000-08-14 AU AU64603/00A patent/AU6460300A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001012192A3 (en) | 2001-12-13 |
WO2001012192A2 (en) | 2001-02-22 |
SE9902938D0 (en) | 1999-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
AU3192700A (en) | Medicinal compositions | |
HUP0202513A2 (en) | Betha-carboline pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU1071301A (en) | Pharmaceutical compounds | |
GB0028088D0 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
GB0001662D0 (en) | Pharmaceutical compositions | |
AU3556400A (en) | Pharmaceutical compositions | |
AU2005300A (en) | Medicinal compositions | |
GB9923436D0 (en) | Pharmaceutical compositions | |
AU1887401A (en) | Medicinal composition | |
AU4328800A (en) | Pharmaceutical formulation | |
AU1735001A (en) | Cyclodextrin-containing pharmaceutical composition | |
AU6715600A (en) | Pharmaceutical formulations | |
GB9904163D0 (en) | Pharmaceutical compositions | |
AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
AU6460400A (en) | Pharmaceutical compositions | |
AU5460800A (en) | Pharmaceutical transdermal compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
GB9911017D0 (en) | Pharmaceutical compositions | |
AU2681500A (en) | Rapidly-soluble compositions | |
AU4977300A (en) | Pharmaceutical formulations | |
AU6460200A (en) | Pharmaceutical compositions | |
AU1385801A (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |